ISIS Pharma Called A 'Sleeper Awakening' At Piper Jaffray
November 05, 2015 at 10:25 AM EST
ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS) shares are down 12 percent year-to-date, after hitting a high of $77.08 on March ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.